Internal Medicine, Infectious Disease · Atlantis, FL
NPI
1689657090
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5401 S Congress Ave Ste 201
Atlantis, FL, 33462
Phone (561) 967-0101
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
1,486 services
Medicare patients, 2024
296
Average age 76
Drug cost, 2024
$4.0M
1,774 prescriptions
Company payments, 2025
$6,000
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Larry M Bush was code 99232 (hospital e&m - subsequent), 1,051 times for 180 patients. In total Larry M Bush billed 1,486 services in 10 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,051 | 180 | $63.29 | $67K |
| 99223 Hospital E&M - Initial | Facility | 194 | 175 | $138.92 | $27K |
| 99214 Office E&M - Established | Office | 171 | 85 | $90.32 | $15K |
| 99205 Office E&M - New | Office | 40 | 40 | $169.63 | $6,785 |
By year: 2022 $160K for 1,975 services; 2023 $113K for 1,339 services; 2024 $118K for 1,486 services.
Medicare prescription drug claims, 2024
In 2024, the drug Larry M Bush prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 412 prescriptions and refills. In total Larry M Bush wrote 1,774 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 412 | 418 | 47 | $1.2M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 337 | 337 | 38 | $1.3M |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 88 | 88 | 11 | $335K |
| Juluca Dolutegravir/Rilpivirine | 85 | 85 | Under 11 | $300K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 67 | 67 | Under 11 | $313K |
| Doxycycline Hyclate Generic | 51 | 57 | 20 | $564 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 47 | 51 | 12 | $350 |
| Descovy Emtricitabine/Tenofov Alafenam | 39 | 39 | Under 11 | $84K |
| Valacyclovir Valacyclovir Hcl | 37 | 53 | Under 11 | $641 |
| Lamivudine-Zidovudine Lamivudine/Zidovudine | 30 | 32 | Under 11 | $5,307 |
| Isentress Raltegravir Potassium | 29 | 29 | Under 11 | $60K |
| Prezcobix Darunavir/Cobicistat | 27 | 27 | Under 11 | $65K |
| Levofloxacin Generic | 25 | 25 | Under 11 | $75.31 |
| Cefdinir Generic | 23 | 25 | 13 | $360 |
| Tivicay Dolutegravir Sodium | 21 | 21 | Under 11 | $46K |
Brand drugs: 1,159 claims; generic drugs: 615 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Larry M Bush $6,000 ($6,000 in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $6,000.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 4 | $6,000 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.